Glenview Capital Management, LLC Teva Pharmaceutical Industries LTD Transaction History
Glenview Capital Management, LLC
- $4.44 Billion
- Q3 2025
A detailed history of Glenview Capital Management, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Glenview Capital Management, LLC holds 16,692,680 shares of TEVA stock, worth $424 Million. This represents 7.6% of its overall portfolio holdings.
Number of Shares
16,692,680
Previous 15,824,223
5.49%
Holding current value
$424 Million
Previous $265 Million
27.14%
% of portfolio
7.6%
Previous 7.47%
Shares
7 transactions
Others Institutions Holding TEVA
# of Institutions
669Shares Held
623MCall Options Held
30.8MPut Options Held
18.5M-
Black Rock Inc. New York, NY43MShares$1.09 Billion0.02% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L341.3MShares$1.05 Billion10.51% of portfolio
-
Menora Mivtachim Holdings Ltd.38.9MShares$989 Million4.08% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.37.7MShares$958 Million6.84% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.32.6MShares$828 Million7.09% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $28.2B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...